Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014:53:111-21.
doi: 10.1159/000358409. Epub 2014 Apr 10.

Stem cells, retinal ganglion cells and glaucoma

Valentin M Sluch  1 , Donald J Zack
Affiliations
Review

Stem cells, retinal ganglion cells and glaucoma

Valentin M Sluch et al. Dev Ophthalmol. 2014.

Abstract

Retinal ganglion cells (RGCs) represent an essential neuronal cell type for vision. These cells receive inputs from light-sensing photoreceptors via retinal interneurons and then relay these signals to the brain for further processing. RGC diseases that result in cell death, e.g. glaucoma, often lead to permanent damage since mammalian nerves do not regenerate. Stem cell differentiation can generate cells needed for replacement or can be used to generate cells capable of secreting protective factors to promote survival. In addition, stem cell-derived cells can be used in drug screening research. Here, we discuss the current state of stem cell research potential for interference in glaucoma and other optic nerve diseases with a focus on stem cell differentiation to RGCs.

PubMed Disclaimer

References

    1. Quigley HA. Open-angle glaucoma. N Engl J Med. 1993 Apr 15;328(15):1097–1106. - PubMed
    1. Nickells RW, Howell GR, Soto I, John SWM. Under Pressure: Cellular and Molecular Responses During Glaucoma, a Common Neurodegeneration with Axonopathy. Annu Rev Neurosci. 2012;35:153–179. - PubMed
    1. Welsbie DS, et al. Functional genomic screening identifies dual leucine zipper kinase as a key mediator of retinal ganglion cell death. Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):4045–4050. - PMC - PubMed
    1. Quigley HA. Clinical trials for glaucoma neuroprotection are not impossible. Curr Opin Ophthalmol. 2012 Mar;23(2):144–154. - PubMed
    1. Sena DF, Lindsley K. Neuroprotection for treatment of glaucoma in adults. Cochrane Database Syst Rev. 2013 Feb 28;2:CD006539. - PMC - PubMed